×
Hero Background

Renal Denervation Companies

ID: MRFR/MED/5249-HCR
115 Pages
Kinjoll Dey
October 2025

Renal denervation is a medical procedure that involves the use of radiofrequency or ultrasound energy to disrupt the nerve signals in the renal arteries, leading to a reduction in blood pressure. This innovative approach has gained attention as a potential treatment for hypertension, a condition that affects millions of people worldwide.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Renal Denervation Market Research Report - Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Renal Denervation Market

Renal Denervation Market

 


Latest Renal Denervation Companies Updates:


FDA Approves Two Renal Denervation Systems: In July 2023, the FDA granted marketing authorization for two renal denervation systems: Medtronic's Symplicity Spyral Renal Denervation System and ReCor Medical's Paradise Ultrasound Renal Denervation System. This marks a significant milestone for the market, opening up access to this potential therapy for patients with uncontrolled hypertension.


Medtronic and ReCor are actively pursuing market entry, partnering with healthcare providers and seeking wider insurance coverage for renal denervation procedures.


List of Renal Denervation Key companies in the market:




  • Boston Scientific,




  • Medtronic,




  • ReCor Medical,




  • St. Jude Medical,




  • Cardiosonic, Cordis,




  • Kona Medical,




  • Sound Intervention,




  • Terumo